1.Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function.
Yuheng JIN ; Xuxin QI ; Xiaoli YU ; Xirui CHENG ; Boya CHEN ; Mingfei WU ; Jingyu ZHANG ; Hao YIN ; Yang LU ; Yihui ZHOU ; Ao PANG ; Yushen LIN ; Li JIANG ; Qiuqiu SHI ; Shuangshuang GENG ; Yubo ZHOU ; Xiaojun YAO ; Linjie LI ; Haiting DUAN ; Jinxin CHE ; Ji CAO ; Qiaojun HE ; Xiaowu DONG
Acta Pharmaceutica Sinica B 2025;15(3):1659-1679
HDAC7, a member of class IIa HDACs, plays a pivotal regulatory role in tumor, immune, fibrosis, and angiogenesis, rendering it a potential therapeutic target. Nevertheless, due to the high similarity in the enzyme active sites of class IIa HDACs, inhibitors encounter challenges in discerning differences among them. Furthermore, the substitution of key residue in the active pocket of class IIa HDACs renders them pseudo-enzymes, leading to a limited impact of enzymatic inhibitors on their function. In this study, proteolysis targeting chimera (PROTAC) technology was employed to develop HDAC7 drugs. We developed an exceedingly selective HDAC7 PROTAC degrader B14 which showcased superior inhibitory effects on cell proliferation compared to TMP269 in various diffuse large B cell lymphoma (DLBCL) and acute myeloid leukemia (AML) cells. Subsequent investigations unveiled that B14 disrupts BCL6 forming a transcriptional inhibition complex by degrading HDAC7, thereby exerting proliferative inhibition in DLBCL. Our study broadened the understanding of the non-enzymatic functions of HDAC7 and underscored the importance of HDAC7 in the treatment of hematologic malignancies, particularly in DLBCL and AML.
2.Research progress on bidirectional regulation of animal cognitive behavior by microbial-gut-brain axis
Yuqiang WANG ; Xuxin LU ; Cuie DENG ; Yingxian MAO ; Weiwei ZHANG
Journal of Shenyang Medical College 2025;27(5):527-534
Cognitive impairment is one of the manifestations of nervous system injury,which is mainly closely related to neurodegeneration,and the incidence rate is increasing year by year,which has seriously affected the health level of the population.The gut microbiota plays an important role in the health of the body and participates in the regulation of the cognitive behavior of body.The microbiome-gut-brain axis acts as a bridge connecting gut microbiota and the nervous system,and plays a regulatory role between gut microbiota and the nervous system.Therefore,this review summarizes the latest progress in the effects of gut microbiota and nervous system on the cognitive ability of body through the bidirectional regulation of neurotransmitters,gut microbiota derivatives,neuroinflammation,oxidative stress,autophagy and their crosstalk through the microbial-intestinal-brain axis,and providing a reference for the clinical research of targeted transplantation of gut microbiota for preventing and treating cognitive disorders.
3.Research progress on the application of digital health in self-management of chronic low back pain
Xuxin WANG ; Junwei LU ; Su'e YUAN
Chinese Journal of Modern Nursing 2025;31(17):2348-2353
Chronic low back pain has become a leading cause of disability worldwide, significantly impairing individuals' quality of life and imposing a heavy burden on families and society. With the rapid advancement of mobile devices and digital information technologies, digital health interventions are increasingly being applied to the management of chronic low back pain. This review provides an overview of self-management in chronic low back pain patients, the background and current development of digital health, the forms of digital health applications in chronic low back pain self-management, and the effects of such interventions. The aim is to offer new perspectives for research on self-management of chronic low back pain.
4.Research progress on bidirectional regulation of animal cognitive behavior by microbial-gut-brain axis
Yuqiang WANG ; Xuxin LU ; Cuie DENG ; Yingxian MAO ; Weiwei ZHANG
Journal of Shenyang Medical College 2025;27(5):527-534
Cognitive impairment is one of the manifestations of nervous system injury,which is mainly closely related to neurodegeneration,and the incidence rate is increasing year by year,which has seriously affected the health level of the population.The gut microbiota plays an important role in the health of the body and participates in the regulation of the cognitive behavior of body.The microbiome-gut-brain axis acts as a bridge connecting gut microbiota and the nervous system,and plays a regulatory role between gut microbiota and the nervous system.Therefore,this review summarizes the latest progress in the effects of gut microbiota and nervous system on the cognitive ability of body through the bidirectional regulation of neurotransmitters,gut microbiota derivatives,neuroinflammation,oxidative stress,autophagy and their crosstalk through the microbial-intestinal-brain axis,and providing a reference for the clinical research of targeted transplantation of gut microbiota for preventing and treating cognitive disorders.
5.Research progress on the application of digital health in self-management of chronic low back pain
Xuxin WANG ; Junwei LU ; Su'e YUAN
Chinese Journal of Modern Nursing 2025;31(17):2348-2353
Chronic low back pain has become a leading cause of disability worldwide, significantly impairing individuals' quality of life and imposing a heavy burden on families and society. With the rapid advancement of mobile devices and digital information technologies, digital health interventions are increasingly being applied to the management of chronic low back pain. This review provides an overview of self-management in chronic low back pain patients, the background and current development of digital health, the forms of digital health applications in chronic low back pain self-management, and the effects of such interventions. The aim is to offer new perspectives for research on self-management of chronic low back pain.

Result Analysis
Print
Save
E-mail